Health Behavior Change During COVID-19 Pandemic
2021年8月8日 更新者：University of Social Sciences and Humanities, Warsaw
Health Behavior Change During COVID-19 Pandemic: the Focus on Handwashing
This study aims at investigating handwashing behavior during COVID-19 pandemic.
It was hypothesized that social-cognitive and emotional predictors as well as COVID-19 morbidity and mortality rates within the country would be associated with handwashing behavior in the general population of adults in 14 countries.
調査の概要
詳細な説明
This observational study aims at testing the adherence to handwashing guidelines (the World Health Organization, WHO, 2020) at two measurement points, spanning 1 month.
Adults from the general population in 14 countries (Poland, Australia, Canada, China, France, Gambia, Germany, Israel, Italy, Malaysia, Portugal, Romania, Singapore, Switzerland) will provide self-report data on handwashing behavior and its social-cognitive predictors (perceived effectiveness of handwashing, risk perception, outcome expectancy, self-efficacy, intention, planning, and action control), anxiety, as well as COVID-19 morbidity and mortality rates within the country.
研究の種類
観察的
入学 (実際)
6079
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
-
Ramat Gan、イスラエル
- Bar-Ilan University
-
-
-
-
-
Padova、イタリア
- University of Padova
-
-
-
-
-
Melbourne、オーストラリア
- The University of Melbourne
-
-
-
-
-
Fredericton、カナダ
- University of New Brunswick
-
-
-
-
-
Fajara、ガンビア
- London School of Hygiene and Tropical Medicine (in collaboration with MRC Unit The Gambia at LSHTM)
-
-
-
-
-
Singapore、シンガポール
- Nanyang Technological University
-
-
-
-
-
Zürich、スイス
- University of Zurich
-
-
-
-
-
Berlin、ドイツ
- Freie Universität Berlin
-
-
-
-
-
Bordeaux、フランス
- University of Bordeaux
-
-
-
-
-
Lisbon、ポルトガル
- University of Lisbon
-
-
-
-
Lower Silezia
-
Wroclaw、Lower Silezia、ポーランド、53-328
- SWPS University of Social Sciences and Humanities
-
-
-
-
-
Serdang、マレーシア
- Perdana University
-
-
-
-
-
Cluj-Napoca、ルーマニア
- Babes-Bolyai Unversity
-
-
-
-
-
Beijing、中国
- Peking University
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
18年歳以上 (大人、高齢者)
健康ボランティアの受け入れ
はい
受講資格のある性別
全て
サンプリング方法
非確率サンプル
調査対象母集団
Adults in 14 countries are recruited using the snowballing method.
Data are collected using an online platform (software: Qualtricts).
説明
Inclusion Criteria:
- adults (from general population) who provided informed consent to participate
Exclusion Criteria:
- younger than <18 years old
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Poland
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Australia
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Canada
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
China
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
France
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Gambia
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Germany
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Israel
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Italy
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Malaysia
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Portugal
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Romania
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Singapore
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Switzerland
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Handwashing adherence
時間枠：1 month
|
The 12-item self-report measure of adherence to handwashing guidelines across situations (e.g., after visiting public spaces, after touching garbage, etc.) based on the guidelines issued by the World Health Organization and the Centers for Disease Control and Prevention.
The responses are provided on a 4-point scale, ranging from 1 (strongly disagree) to 4 (strongly agree).
Higher scores indicate better outcomes (the higher level of adherence to handwashing guidelines).
|
1 month
|
|
Frequency of handwashing
時間枠：1 month
|
The 1-item self-report measure of the frequency of handwashing (for at least 20 seconds, all surfaces of the hands) daily.
The responses are provided on a 4-point scale, ranging from 1 (less than once) to 5 (more than 10 times).
Higher scores indicate better outcomes (the higher frequency of handwashing).
|
1 month
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Self-efficacy
時間枠：1 month
|
4 self-efficacy questionnaire items; mean item score ranging from 1 to 4, higher scores indicate stronger self-efficacy
|
1 month
|
|
Risk perception
時間枠：1 month
|
3 questionnaire items to assess risk perception; mean item score ranging from 1 to 5, higher scores indicate higher risk perception
|
1 month
|
|
Outcome expectancy
時間枠：1 month
|
4 items assessing positive (1 item) and negative (1 items) outcome expectancies; mean item scores ranging from 1 to 4, higher scores indicate more positive outcome expectancies
|
1 month
|
|
Intention
時間枠：1 month
|
2 questionnaire items assessing intention to adhere to handwashing recommendations; mean item scores ranging from 1 to 4, higher scores indicate stronger intention to wash hands (for at least 20 seconds, all surfaces of the hands)
|
1 month
|
|
Planning
時間枠：1 month
|
2 questionnaire items assessing action planning (1 item) and coping planning (1 item); mean item scores ranging from 1 to 4, higher scores indicate a higher level of self-reported planning
|
1 month
|
|
Action control
時間枠：1 month
|
3 questionnaire items assessing a facet of action control, namely self-monitoring; mean item scores ranging from 1 to 4, higher scores indicate a higher level of self-reported monitoring of handwashing behavior
|
1 month
|
|
Perceived effectiveness of hand hygiene
時間枠：1 month
|
1 questionnaire item assessing perceptions of handwashing as an effective means of preventing coronavirus SARS-CoV-2 infection; item scores ranging from 1 to 4, higher scores indicate a higher level of perceived effectiveness of hand hygiene
|
1 month
|
|
Anxiety
時間枠：1 month
|
7-item self-report scale (Generalized Anxiety Disorder, GAD-7) scale to assess anxiety symptoms; mean item scores ranging from 1 to 4, higher scores indicate a higher level of generalized anxiety
|
1 month
|
|
Country-level COVID-19 morbidity and mortality rates
時間枠：60 days
|
The daily cumulative numbers for COVID-19 morbidity and mortality in the study countries.
Published daily as the Situation Report by World Health Organization, starting on 21 January 2020.
Higher numbers indicate the higher cumulative COVID-19 morbidity and mortality rates in the country.
|
60 days
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
捜査官
- 主任研究者：Aleksandra Luszczynska, PhD、SWPS University of Social Sciences and Humanities
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
一般刊行物
- Schwarzer R, Lippke S, Luszczynska A. Mechanisms of health behavior change in persons with chronic illness or disability: the Health Action Process Approach (HAPA). Rehabil Psychol. 2011 Aug;56(3):161-70. doi: 10.1037/a0024509.
- World Health Organization. Coronavirus disease (COVID-19) advice for the public. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
- Centers for Disease Control and Prevention. When and how to wash your hands. 2020. https://www.cdc.gov/handwashing/when-how-handwashing.html
- Reyes Fernandez B, Knoll N, Hamilton K, Schwarzer R. Social-cognitive antecedents of hand washing: Action control bridges the planning-behaviour gap. Psychol Health. 2016 Aug;31(8):993-1004. doi: 10.1080/08870446.2016.1174236. Epub 2016 Apr 26.
- Ruiter RAC, Abraham C, Kok G. Scary warnings and rational precautions: A review of the psychology of fear appeals. Psychol Health. 2011;11(1): 613-630. doi: 10.1080/08870440108405863
- Luszczynska A, Szczuka Z, Abraham C, Baban A, Brooks S, Cipolletta S, Danso E, Dombrowski SU, Gan Y, Gaspar T, de Matos MG, Griva K, Jongenelis MI, Keller J, Knoll N, Ma J, Miah MAA, Morgan K, Peraud W, Quintard B, Shah V, Schenkel K, Scholz U, Schwarzer R, Siwa M, Taut D, Tomaino SCM, Vilchinsky N, Wolf H. The Interplay Between Strictness of Policies and Individuals' Self-Regulatory Efforts: Associations with Handwashing During the COVID-19 Pandemic. Ann Behav Med. 2022 Apr 2;56(4):368-380. doi: 10.1093/abm/kaab102.
- Szczuka Z, Abraham C, Baban A, Brooks S, Cipolletta S, Danso E, Dombrowski SU, Gan Y, Gaspar T, de Matos MG, Griva K, Jongenelis M, Keller J, Knoll N, Ma J, Miah MAA, Morgan K, Peraud W, Quintard B, Shah V, Schenkel K, Scholz U, Schwarzer R, Siwa M, Szymanski K, Taut D, Tomaino SCM, Vilchinsky N, Wolf H, Luszczynska A. The trajectory of COVID-19 pandemic and handwashing adherence: findings from 14 countries. BMC Public Health. 2021 Oct 5;21(1):1791. doi: 10.1186/s12889-021-11822-5.
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2020年3月25日
一次修了 (実際)
2020年9月24日
研究の完了 (実際)
2020年9月24日
試験登録日
最初に提出
2020年4月28日
QC基準を満たした最初の提出物
2020年4月28日
最初の投稿 (実際)
2020年4月29日
学習記録の更新
投稿された最後の更新 (実際)
2021年8月10日
QC基準を満たした最後の更新が送信されました
2021年8月8日
最終確認日
2020年8月1日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 3228-1BPSYPSBEH-30
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
未定
IPD プランの説明
The lead researchers in 14 countries will have full access to data collected across the countries.
In line with the Consortium Agreement (v2, 16th Jul 2020) data will be openly available under following conditions:
De-identified individual participant data that underline the results reported in publications; individual-level aggregated data (e.g., sum scores for scales) used for main analyses in respective publications; available following the publication, no end date of availability; available for analyses that are conducted to achieve aims in the approved proposal.
Due to local regulations, there are exceptions in terms of data sharing rules (stated above):
- AUSTRALIA: Data from Australia will be available for 5 years after collection.
- GERMANY, SWITZERLAND: Instead of individual-level sum scores, variance-covariance matrices will be shared.
- MALAYSIA: Data will not be shared.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
健康行動の臨床試験
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National... と他の協力者完了
-
Seattle Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National... と他の協力者まだ募集していません
-
Queens College, The City University of New York募集American Journal of Public Healthに投稿された論文の出版アメリカ
-
Hopital MontfortChildren's Hospital of Eastern Ontario Research Institute募集熱ストレス障害 | 一次医療 | 環境暴露 | リスク軽減行動 | 公衆衛生 | 熱暴露 | 気候変動 | 予防医療サービス (PREV HEALTH SERV) | ヒースリー被験者カナダ
No interventionの臨床試験
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical Center; Tobacco Related Disease Research Program完了
-
University of Southern CaliforniaNational Institutes of Health (NIH)積極的、募集していない
-
University of MichiganNational Institute on Drug Abuse (NIDA)完了
-
University of PittsburghCenters for Disease Control and Prevention募集暴力, ドメスティック | 思春期の暴力 | 暴力、性的 | 暴力、身体的 | 暴力, 偶然ではない | 社会的結束 | 暴力、構造 | コミュニティ内暴力アメリカ